Viewpoints: Destroying the reputation of a vaccine will harm everyone; The next fiscal reaction is long overdue


Editorial pages focus on these and other pandemic topics.

Statistics: The further development of a Covid-19 vaccine means counteracting the denial of science

In the divided public dialogue about Covid-19, one point of agreement stands out: An effective vaccine is what you need to stop or at least control the pandemic. The anti-vaccine movement could derail that solution. To stop Covid-19, many people – most people really – would either have to have survived infection with SARS-CoV-2, the virus that causes the disease, or be vaccinated against it. By sowing doubt and denial, antivaxxers could lead many people not to get a vaccine, thereby making the virus persistent and permanently infectious. (Jonathan M. Berman, 9/9)

USA Today: The frenzied “Holy Grail” coronavirus vaccine could turn into a curse

It would be the cruelest irony if Donald Trump’s great quest for salvation after so many coronavirus failures – through the rapid manufacture of a vaccine – also fails due to mismanagement. The president is betting on buying what his campaign advisors call the “Holy Grail” by election day. “We’ll have a vaccine very soon, maybe even before a very special date. You know what date I’m talking about,” teased Trump on Monday. It would be an ultimate achievement totem over a virus that, under Trump’s watch, has ruined the economy and killed nearly 190,000 Americans, more casualties than any other nation in the world. (9/8)

Bloomberg: Covid-19 vaccine policy demands more from developers like Pfizer and Moderna

With President Donald Trump repeatedly announcing the possibility of a Covid-19 vaccine being approved by election day, the companies he needs for it are pushing back. And that’s good all round. On Tuesday, nine major coronavirus vaccine developers – including Pfizer Inc., AstraZeneca Plc, and Moderna Inc. – signed a joint pledge pledging not to submit their vaccinations for Food and Drug Administration approval until they were safe and Efficacy in large-scale end-stage study. It’s an unusual statement; Typically, the FDA defends high standards while drug manufacturers try to push boundaries. Unprecedented political pressure, combined with public unease about a potentially hasty process, has forced roles to be reversed. (Max Nisen, August 9th)

The Washington Post: Kamala Harris doubts pre-election vaccine, is shameful

Democrats have accused President Trump of endangering public health with his reluctant support for the wearing of masks. But this weekend, Democratic nominee for Vice President Senator Kamala D. Harris, California, did something much worse. In a CNN interview, Harris repeatedly asked whether it would be safe to take the coronavirus vaccines developed as part of the Trump administration’s Operation Warp Speed. (Marc A. Thiessen, August 9th)

The Washington Post: The economy needs another round of fiscal support. The impasse of Congress must come to an end.

Congress returned from hiatus on Tuesday, with very little time before the first week of October when the House and Senate legislative calendars prompted lawmakers to take a hiatus before the November 3 election – and two important tasks are to be fulfilled. On the first of these, progress has been made to avoid a government shutdown if the current spending agency expires on September 30th: House Spokeswoman Nancy Pelosi (D-California) and Treasury Secretary Steven Mnuchin have announced they have a quick Pass an interim law that will keep federal employees paid and operations at least during the elections. However, the second major task of Congress, which is to give the economy another dose of fiscal support, remains a dead end. It has to come to an end. (9/8)

Boston Globe: Federal Aid Needed As COVID-19 Continues To Devastate Low Income Households

As the Boston area’s anti-poverty and community action organization, ABCD has a bird’s-eye view of the pain of poverty that grips the Boston neighborhoods and the nearby cities and towns in which we serve – a pain that reflects the fear which is felt across the state and across the nation. In a recent survey by the Center on Budget and Policy Priorities, millions said their households did not have enough to eat or were behind on rent payments. The negative effects of the pandemic are particularly widespread among Black, Latin American, Native American, and immigrant households. These effects reflect harsh, long-standing injustices – often stemming from systemic racism – in education, employment, housing, and health care exacerbated by the coronavirus pandemic. (John J. Drew, 9/9)

The Wall Street Journal: Medical Research Gold Cross puts Covid treatments at risk

You have probably heard of the “gold standard” – randomized controlled trials – for evaluating new pharmaceutical therapies, including Covid-19. Many treatments that showed promise in other studies have shown murky results in randomized controlled trials. But that doesn’t mean they are necessarily ineffective. Physicians and regulators must consider the body of medical evidence when treating patients. (Allysia Finley, Aug 9)

Los Angeles Times: Positive coronavirus tests shock my asymptomatic patients

As a doctor, I am part of a COVID-19 task force that contacts coronavirus-positive patients and clarifies the next steps in their care. When I tell them that their test result is positive, many people get confused and say they are “fine”. So I was more than dismayed when the Centers for Disease Control and Prevention appeared to give in to political pressure to change their COVID-19 policies and discourage testing on asymptomatic individuals. When the CDC recently issued new guidelines that no longer recommend testing people who are feeling fine but have been in close contact with someone who has COVID-19, the medical community and politicians across the country raised the alarm. More than one expert indicated that the guidelines had been revised for political rather than scientific reasons. (Zainab Saddi, 9/9)

Bloomberg: School Reopening In The Pandemic: Learning From The Fiasco In New York City

New York City, the epicenter of last spring’s coronavirus pandemic and the largest public school district planning to start at least one face-to-face class, botched its reopening plans for the fall. His mistakes are a warning to school systems in the United States struggling to weigh the benefits of resuming their education programs against the risks of spreading Covid-19. The New York Department of Education’s piecemeal planning and poor communication led to requests from dozens of principals, districts, and councilors to postpone the opening date, and eventually sparked threats of a teachers’ strike. (Andrea Gabor, 9/2)

The Hill: Pandemic requires partnerships like never before

At the start of the fall semester, we already saw colleges and universities try to open up just to reverse course while others take extraordinary measures to stay open. Meanwhile, coronavirus cases continue to rise across the country. As school principals grapple with what to do, they must recognize that their choices have massive health implications for the cities and towns in which they live – whether or not college students are at serious risk of disease themselves. (Shirley M. Collado and Svante Myrick, 9/8)

St. Louis Post Dispatch: Grocery workers still on the front lines of the pandemic but with no Hazardous Assets

In Missouri, frontline workers continue to emerge for our communities every day, despite the very real dangers they still face. The men and women who work in your local grocery stores are exposed to the potentially thousands of customers daily who put their health at risk in order to serve their communities. Without the courage of these important grocery store workers who continue to put themselves at risk, our families would not have the food we need in this crisis. With the growing risks that spread as coronavirus cases continue to spread, it is time the executives of every grocery chain in Missouri stepped up and guarantee a hazard payment for all of these frontline workers. (David Cook, 9/7)

The Hill: Congress Must Protect Patients With Kidney Disease During COVID-19 Pandemic

As we continue to address the unprecedented health and economic emergency posed by COVID-19, it is critically important that we take all possible steps to ensure the health of vulnerable patient populations, including the nearly 38 million Americans living with chronic kidney disease (CKD) To suffer. Before this crisis erupted, kidney patients faced major barriers to accessing health care. With a growing body of research, government data, and CDC warnings showing the disproportionate impact of COVID-19 on kidney patients, especially minorities, policymakers must now take proactive steps to ensure that CKD patients have safe access to care while avoiding exposure. (Paul Conway, 9/8)

This is part of the KHN Morning Briefing, a round-up of health coverage from major news organizations. Sign up for an email subscription.


Previous Ease of EMI payments, cash in Jan Dhan accounts on government anvil to ease coronavirus burden
Next Current bonus categories: Chase, Discover & Citi